Delivery Order 75N92020D00022-75N92021F00011

This is a firm fixed price delivery order awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a for-profit manufacturer of sequencing and array-based analytical instruments and reagents. The $130,354.54 contract is for the provision of REAGENT (CHEMISTRY) KITS with a completion date of September 14, 2022. Illumina is a well-established provider of genomic sequencing solutions to various federal agencies, including the National Institutes of...

The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a $156,650.78 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer, for the provision of various sequencing reagents and kits to support the NIH's Center for Cellular Engineering (CCE). This includes NextSeq 500/550 v2.5 sequencing reagent kits, PhiX Control v3 kits, and related technical support. The contract has no set-aside designation and is being issued under...

This is a delivery order for REAGENT (CHEMISTRY) KITS awarded to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis solutions. The $60,125.97 firm fixed price award is from the Department of Health and Human Services Food and Drug Administration, and does not have a set-aside designation. Illumina has a history of providing sequencing systems, reagents, and related analytical products and services to support genomics research and diagnostics across various federal...

This contract was awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $13,943.66 firm fixed price delivery order is for reagents to support next-generation sequencing experiments in Dr. Calvo's laboratory. There is no set-aside designation for this contract. Illumina has previously received prime federal contracts and subcontracts from agencies such as the NIH, Centers...

This is a firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $149,969.30 contract is for the provision of NextSeq 1000/2000 XLEAP-SBS reagent kits and NextSeq PhiX control kits. The award has a performance period ending on May 30, 2025. Illumina has previously provided sequencing systems, reagents, and services to support genomic...

This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $277,984.22, is for the provision of REAGENT (CHEMISTRY) KITS with a period of performance through September 30, 2022. There is no set-aside designation noted. Based on Illumina's background as a provider of genomic sequencing systems and consumables to...

The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the supply of REAGENT (CHEMISTRY) KITS. The $208,133.41 contract has no set-aside designation and the items are intended to support the agency's life science research and molecular diagnostics programs. Illumina has previously received prime federal contracts from agencies like the...

The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents, for the provision of "REAGENT (CHEMISTRY) KITS". The contract, valued at $52,069.01, has an end date of October 31, 2022 and does not have any set-aside designation. Illumina has previously provided sequencing instruments, reagents, and bioinformatics products to support genomic...

This is a firm fixed price delivery order awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $149,599.29 contract is for the delivery of chemistry reagent kits used in the company's sequencing systems. Illumina is the sole manufacturer of the specific instruments referenced, which are utilized across government agencies like the NIH, CDC, and VA for genomic research...

The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The $225,026.28 contract is for the supply of reagent chemistry kits and does not have a set-aside designation. Illumina has a history of providing sequencing systems, reagents, and related products and services to support genomic research and diagnostics across various...